Pub. Date : 2021 Jul-Aug 01
PMID : 31567201
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Clinical Experience With 75-mg Dose of Erlotinib for Mutated Metastatic EGFR Non-small Cell Lung Cancer. | erlotinib | epidermal growth factor receptor | Homo sapiens |
| 2 | Erlotinib is a reversible epidermal growth factor receptor (EGFR) inhibitor, which was approved at its maximum tolerated dose of 150 mg/d determined from the initial phase I study. | erlotinib | epidermal growth factor receptor | Homo sapiens |
| 3 | Erlotinib is a reversible epidermal growth factor receptor (EGFR) inhibitor, which was approved at its maximum tolerated dose of 150 mg/d determined from the initial phase I study. | erlotinib | epidermal growth factor receptor | Homo sapiens |